Helsinn Advanced Synthesis Discontinued
FDA Approved Drugs

Helsinn Advanced Synthesis Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 6
  • Latest Approval Date May 28, 2021
  • Data Source FDA
  • First Approval Date Jul 25, 2003
All
9
View
Discontinued
6
View
RX
3
View
Company Overview

Company

Helsinn Advanced Synthesis Discontinued

Country

Switzerland

Website

Visit Website

Email

manufacturing@helsinn.com

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Helsinn Advanced Synthesis Discontinued

Via Industria 246710 Biasca – Switzerland

Switzerland

helsinn.com/ manufacturing@helsinn.com View on Map
FDA Approved Drug Records ( 6 records )
2018
19 Apr
Discontinued Application: 210493

Drug Name

AKYNZEO

Product Number

1

Dosage Form

-

Strength

EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL

Approval Date

2018-04-19

210493 / 1

Active Ingredient

FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE

Application Number

210493

Product Number

1

Dosage Form

-

Strength

EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL

Approval Date

2018-04-19

Regulatory Status

Discontinued

2003
25 Jul
Discontinued Application: 21372

Drug Name

ALOXI

Product Number

1

Dosage Form

-

Strength

EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2003-07-25

21372 / 1

Active Ingredient

PALONOSETRON HYDROCHLORIDE

Application Number

21372

Product Number

1

Dosage Form

-

Strength

EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2003-07-25

Regulatory Status

Discontinued

2008
29 Feb
Discontinued Application: 21372

Drug Name

ALOXI

Product Number

2

Dosage Form

-

Strength

EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2008-02-29

21372 / 2

Active Ingredient

PALONOSETRON HYDROCHLORIDE

Application Number

21372

Product Number

2

Dosage Form

-

Strength

EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2008-02-29

Regulatory Status

Discontinued

2008
22 Aug
Discontinued Application: 22233

Drug Name

ALOXI

Product Number

1

Dosage Form

-

Strength

EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2008-08-22

22233 / 1

Active Ingredient

PALONOSETRON HYDROCHLORIDE

Application Number

22233

Product Number

1

Dosage Form

-

Strength

EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2008-08-22

Regulatory Status

Discontinued

2021
28 May
Discontinued Application: 214622

Drug Name

TRUSELTIQ

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2021-05-28

214622 / 1

Active Ingredient

INFIGRATINIB PHOSPHATE

Application Number

214622

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2021-05-28

Regulatory Status

Discontinued

2021
28 May
Discontinued Application: 214622

Drug Name

TRUSELTIQ

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2021-05-28

214622 / 2

Active Ingredient

INFIGRATINIB PHOSPHATE

Application Number

214622

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2021-05-28

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    2 View
  • EDQM CEP
    4 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    9 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
6 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

AKYNZEO

Application Number

210493

Product Number

1

Active Ingredient

FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE

Dosage Form

-

Strength

EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit